Paracetamol + Codeine phosphate hemihydrate
This medicine should always be used exactly as described in this patient leaflet or as directed by your doctor or pharmacist.
1 What is Paracetamol + Codeine APAP and what is it used for
Paracetamol + Codeine APAP is a pain reliever. It contains two active substances with a pain-relieving effect: paracetamol and codeine. Codeine belongs to a group of medicines called opioid pain relievers, which relieve pain. It can be used alone or in combination with other pain relievers, such as paracetamol.
This medicine is used to treat moderate to severe pain of various origins, such as: headache, tooth extraction pain, bone and joint pain (also post-traumatic), post-traumatic soft tissue pain, menstrual pain, neuralgia.
In the treatment of moderate acute pain that does not respond to other pain relievers, such as paracetamol or ibuprofen (used alone), codeine can be used in adolescents aged 12 and over.
Do not take the medicine for longer than recommended. The duration of treatment should be limited to 3 days.
Taking pain relievers for headaches too frequently or for a long time can make them worse.
Before starting to take this medicine, you should discuss it with your doctor or pharmacist if you are or have ever been dependent on opioids, alcohol, prescription medicines, or illegal substances.
Taking codeine (the active substance of this medicine) regularly and for a long time can lead to dependence and misuse, which can cause overdose and/or death. Do not take this medicine for longer than necessary. Do not give this medicine to others.
While taking this medicine, do not take other medicines containing codeine or paracetamol (including those available on prescription or over-the-counter), so as not to exceed the recommended daily dose (see section 3).
Codeine is converted to morphine by liver enzymes. Morphine is a substance that relieves pain. Some people have a changed enzyme and it can affect them in different ways.
In some people, morphine is not produced or is produced in very small amounts, which does not provide adequate pain relief. Other people are more prone to severe side effects caused by the production of very large amounts of morphine (see When not to take Paracetamol + Codeine APAP). If you experience any of the following side effects, you should stop taking this medicine and consult your doctor immediately: slow or shallow breathing, disorientation, drowsiness, constricted pupils, nausea or vomiting, constipation, loss of appetite.
In the event of the above situations, you should consult your doctor or pharmacist before taking this medicine and then follow their instructions.
In the above cases, paracetamol should be taken with special caution.
Do not give this medicine to children under 12 years old due to the risk of opioid toxicity (the medicine is contraindicated).
It is not recommended to use this medicine in adolescents aged 12 to 18 with respiratory function disorders, in the symptomatic treatment of cough and/or cold.
Use in children and adolescents after surgical removal of tonsils or adenoids
The medicine should not be used to relieve pain in children and adolescents after tonsillectomy or adenoidectomy in connection with obstructive sleep apnea syndrome (see When not to take Paracetamol + Codeine APAP).
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take.
This is especially important for medicines such as:
Tell your doctor or pharmacist if you are taking:
While taking the medicine, you should not drink alcoholic beverages or take medicines containing alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, you should consult your doctor or pharmacist before taking this medicine.
The medicine is contraindicated during pregnancy and breastfeeding (see When not to take Paracetamol + Codeine APAP).
The medicine can cause dizziness and drowsiness. Do not take this medicine while driving or operating machinery.
The medicine contains 0.32 mg of soybean lecithin (E 322) per tablet. The medicine is contraindicated in case of known hypersensitivity to peanuts or soy (see When not to take Paracetamol + Codeine APAP).
This medicine should always be taken exactly as described in this patient leaflet or as directed by your doctor or pharmacist. In case of doubt, you should consult your doctor or pharmacist.
The recommended dose is:
Adults and adolescents over 16 years old:
1 to 2 tablets up to 4 times a day, at 6-hour intervals. Maximum 6 tablets per day (which corresponds to 3000 mg of paracetamol and 90 mg of codeine phosphate per day).
Adolescents aged 12-15:
1 tablet at 6-hour intervals. Maximum 4 tablets per day (which corresponds to 2000 mg of paracetamol and 60 mg of codeine phosphate per day).
Children under 12 years old:
The medicine is contraindicated in this patient group.
Elderly patients:
In elderly and weakened patients, a dose reduction may be necessary; consult your doctor.
Patients with kidney and/or liver function disorders:
Patients diagnosed with kidney function disorders, liver function disorders, or Gilbert's syndrome must consult their doctor before taking the medicine.
Method of administration
Oral. The tablets can be broken in half to make them easier to swallow.
In case of taking a larger dose of the medicine than recommended, you should immediately consult your doctor or go to the nearest hospital, even if you feel well, due to the risk of severe liver damage, which may occur with some delay.
You should take the packaging of the medicine you have taken with you.
Concomitant consumption of alcohol and psychotropic medicines can exacerbate overdose symptoms.
The first symptoms of overdose may be: nausea, vomiting, dizziness, drowsiness, loss of appetite, pallor, abdominal pain, bronchospasm, skin reactions in the form of rash, urticaria.
Constricted pupils may be observed. Hypotension and tachycardia are possible but unlikely. Liver damage may be visible after 12 to 48 hours from ingestion. Glucose metabolism disorders may occur. In severe poisonings, liver failure can lead to metabolic acidosis, bleeding, decreased blood sugar levels (hypoglycemia), brain edema, and death. Even in the absence of severe liver damage, acute renal failure with acute tubular necrosis may develop, with loin pain, hematuria, and proteinuria.
Cardiac arrhythmias and pancreatitis have also been observed.
Do not take a double dose to make up for a missed dose.
In case of any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Regularly taking codeine for a long time can lead to dependence, which can cause anxiety and irritability when treatment is stopped.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rare (may occur in less than 1 in 1000 people):vision disorders or constricted pupils*,
tinnitus, dyspnea, dry mouth, allergic rash.
Very rare (may occur in less than 1 in 10,000 people):decreased platelet count (thrombocytopenia), decreased white blood cell count (leukopenia), significant deficiency or lack of a certain group of white blood cells - neutrophils (agranulocytosis), single cases of decreased white blood cell count, red blood cell count, and platelet count (pancytopenia), hypersensitivity reactions, such as angioedema, dyspnea, sweating, malaise, hypotension up to shock**, respiratory depression***, euphoria or dysphoria* (mood disorders with a tendency to irritability, aggression, and explosiveness not adequate to the situation), coordination disorders*, bronchospasm, pulmonary edema* (especially in people with impaired lung function), severe skin reactions.
Frequency not known (cannot be estimated from the available data):very severe allergic reaction (anaphylactic reaction), acute pancreatitis (in people after cholecystectomy), increased liver enzyme activity, excessive sweating, dependence and tolerance (in case of long-term use).
* after taking large doses
** single cases
*** after taking larger doses or in people with increased intracranial pressure or after head injury
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz2.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
There are no special instructions for storing the medicine.
The medicine should be stored out of sight and reach of children.
Do not use after the expiry date stated on the carton and blister pack (month/year). The applied labeling for the blister is: EXP - expiry date, Lot - batch number.
The expiry date refers to the last day of the stated month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substances of the medicine are paracetamol and codeine phosphate hemihydrate.
One coated tablet contains 500 mg of paracetamol and 15 mg of codeine phosphate hemihydrate.
The other ingredients are: maize starch, povidone (K-30), microcrystalline cellulose, maize starch, crospovidone XL 10, colloidal anhydrous silica, magnesium stearate. Coating Opadry AMB white OY-B28920: polyvinyl alcohol, partially hydrolyzed, titanium dioxide (E 171), talc, soybean lecithin (E 322), xanthan gum.
White or almost white, oblong, biconvex coated tablets with dimensions of 17.1 mm x 7.6 mm, with a dividing line on one side and smooth on the other. The dividing line is only for breaking the tablet to make it easier to swallow and does not divide the tablet into equal doses.
A PVC/PVDC/Aluminum blister pack containing 10 coated tablets, in a cardboard box.
US Pharmacia Sp. z o.o.
ul. Ziębicka 40
To obtain more detailed information about this medicine, you should contact:
USP Zdrowie Sp. z o.o.
ul. Poleczki 35
02-822 Warszawa
tel.: +48 (22) 543 60 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.